Skip to main content
. 2011 Nov;55(11):5134–5142. doi: 10.1128/AAC.05028-11

Table 1.

MICs for the P. aeruginosa isolates used in this study

Isolate MIC (mg/liter)a
Cephalosporinase and carbapenemase typing MDRb
Colistin Imipenem
ATCC 27853c 1 2 Negative No
19147 n/m 128 4 IMP and CTX-M positived Yes
19056 muc 0.5 4 Negative Yes
20509 n/mc 0.5 1 Negative No
19271 n/mc 2 32 Negative Yes
20891 n/mc 1 16 Negative Yes
a

CLSI breakpoints for colistin were ≤2 mg/liter for susceptibility, 4 mg/liter for intermediacy, and ≥8 mg/liter for resistance. For imipenem, the breakpoints were ≤4 mg/liter for susceptibility, 8 mg/liter for intermediacy, and ≥16 mg/liter for resistance (10).

b

Defined as diminished susceptibility to ≥2 of the following 5 drug classes: antipseudomonal cephalosporins, antipseudomonal carbapenems, β-lactam-β-lactamase inhibitor combinations, antipseudomonal fluoroquinolones, and aminoglycosides (40).

c

Colistin heteroresistant. Heteroresistance to colistin was defined as the existence, in an isolate for which the colistin MIC was ≤2 mg/liter, of subpopulations able to grow in the presence of >2 mg/liter colistin (55).

d

Contains genes encoding an IMP-type carbapenemase and a CTX-M-type ESBL.

HHS Vulnerability Disclosure